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Abstract The conformation of a transmembrane peptide,
sMTM7, encompassing the cytoplasmic hemi-channel
domain of the seventh transmembrane section of subunit a
from V-ATPase from Saccharomyces cerevisiae solubi-
lized in SDS solutions was studied by circular dichroism
(CD) spectroscopy and Xuorescence spectroscopy of the
single tryptophan residue of this peptide. The results show
that the peptide adopts an -helical conformation or aggre-
gated -sheet depending on the peptide-to-SDS ratio used.
The results are compared with published data about a
longer version of the peptide (i.e., MTM7). It is concluded
that the bulky, positively charged arginine residue located
in the center of both peptides has a destabilizing eVect on
the helical conformation of the SDS-solubilized peptides,
leading to -sheet formation and subsequent aggregation.
Keywords V-ATPase · SDS micelles · 
Secondary structure · Aggregation · 
Membrane-mimicking solvent · Spectroscopy
Abbreviations
CD Circular dichroism
CMC Critical micellar concentration
DMSO Dimethylsulfoxide
DPC Dodecylphophocholine
MTM7 Peptide mimicking the cytoplasmic side of the
seventh transmembrane segment of subunit a
from V-ATPase (from residue 716 to 753)
sMTM7 Peptide mimicking the cytoplasmic side of the
seventh transmembrane segment of subunit a
from V-ATPase (from residue 719 to 745)
SDS Sodium dodecyl sulfate
TFE TriXuoroethanol
V-ATPase Vacuolar proton-translocating adenosine
triphosphatase
Introduction
For the structure determination of transmembrane peptides
and proteins by liquid-state high-resolution NMR spectros-
copy in aqueous solutions, detergents are often used to
solubilize the hydrophobic polypeptide molecules in
micellar-like complexes (Fernandez et al. 2001; Nielsen et al.
2003; Papavoine et al. 1995, 1998; Vinogradova et al. 1998).
It is supposed that in these complexes the detergent micelle
covers the hydrophobic region of the polypeptide, while
possible hydrophilic termini are embedded in the water phase
(Arora et al. 2001). Several studies have shown that trans-
membrane polypeptides can retain and exhibit their natural
conformation when solubilized in SDS solutions at concen-
trations well above the critical micelle concentration (cmc)
(Arora et al. 2001; Henry and Sykes 1994; Lazarova et al.
2004; Papavoine et al. 1994; Underhaug et al. 2006).
Due to its physicochemical characteristics, SDS is considered
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to be an ideal solubilizing detergent for hydrophobic mem-
brane polypeptides; as in biological membranes, it has a
negative net charge and can provide a good interface for the
folding of surface-active peptides (Mammi and Peggion
1990).
Recently conformational studies of transmembrane pep-
tides located in the cytoplasmic hemi-channel region of
TM7 of V-ATPase subunit a have been published, based on
two synthesized peptides: MTM7 and sMTM7 (see Fig. 1)
(Duarte et al. 2007a,  b; Vos et al. 2007). These putative
transmembrane peptides include the arginine residue
(R735), which is known to be part of the proton transloca-
tion channel, interacting with the glutamic acids from the
subunits c, c, and c (Nishi and Forgac 2002). This work
sheds light on the low- and high-resolution structure of this
domain of V-ATPase that is essential for proton transloca-
tion. MTM7 is a 37-residue peptide that was studied in
organic solvents and SDS micellar solutions. In organic
solvents (TFE and DMSO) and SDS micelles, this peptide
adopted an -helical conformation, however, the increase in
the molecular weight of the peptide/SDS micelles ham-
pered the use of NMR spectroscopy to obtain a high-resolu-
tion structure. Peptide sMTM7 is a smaller version of
peptide MTM7 containing 25 residues (see Fig. 1). This
peptide was also studied in organic solvents (Duarte et al.
2007a) and in SDS micellar solutions (Vos et al. 2007). The
relevance of the use of such membrane-mimicking solvents
to study these peptides has been discussed previously
(Duarte et al. 2008). When solubilized in DMSO, peptide
sMTM7 exhibits two -helical regions and a fraying
C-terminal, as determined by high-resolution NMR spec-
troscopy. In SDS micelles, the overall conformation of the
peptide was determined by circular dichroism to be -heli-
cal. Similar to peptide MTM7, the study of peptide sMTM7
in SDS micelles by NMR was impossible due to the strong
broadening and low signal-to-noise ratio of the NMR spectra.
In this paper, we report the conformational behavior of
peptide sMTM7 in diVerent SDS micellar solutions. Circu-
lar dichroism spectroscopy is applied to study the second-
ary structure and thermal stability of the peptide in the
micelles. Taking advantage of the presence of a single tryp-
tophan at position 737 (see Fig. 1), the Xuorescence of pep-
tide sMTM7 was measured enabling us to characterize the
hydrophobicity of the environment that solvates the pep-
tide. Our results indicate that at SDS concentrations above
the cmc, peptide sMTM7 can adopt an -helical or -sheet
conformation depending on the number of SDS molecules
available in solution. In comparing these data with the solu-
bilizing data obtained for the longer peptide MTM7, we
conclude that the bulky, positively charged arginine residue
located in the center of the peptide has a destabilizing eVect
on the helical conformation of the SDS-solubilized peptides,
leading to -sheet formation and subsequent aggregation.
Materials and methods
Peptide design and synthesis
Peptide sMTM7 is composed of 25 residues (Fig. 1) and
was designed based on the putative localization of trans-
membrane segment TM7 located in the cytoplasmic hemi-
channel region of V-ATPase subunit a (Duarte et al.
2007a). The peptide is a smaller version of the 37-residue
peptide MTM7 (Fig. 1) that was used in previous work
(Duarte et al. 2007a). Throughout this paper the sequential
numbering of amino acid residues of peptide sMTM7 is
identical to the one used for subunit a in V-ATPase
(Fig. 1). Peptide sMTM7 was produced on solid support
using continuous Xow chemistry by Pepceuticals, Leicester,
UK. Its purity was tested by mass spectrometry and found
to be larger than 90%.
Solvents
Peptide sMTM7 is a highly hydrophobic peptide with a
poor solubility in DPC micelles, TFE:water mixtures, and
aqueous systems (Duarte et al. 2007a). To perform confor-
mational studies, two membrane-mimicking solvents com-
monly used in the literature were selected: SDS micelles
(SDS from Merck, Darmstadt, Germany), and TFE (Acros
Organics, Geel, Belgium).
Sample preparation
To solubilize peptide sMTM7 in aqueous solutions of SDS,
the peptide was initially dissolved in TFA and dried under a
stream of nitrogen. A 2-mM peptide solution was prepared
in TFE resulting in a clear solution. This peptide solution
was then mixed with a freshly made SDS solution at the
Fig. 1 Primary structure of peptides MTM7 and sMTM7. The
coloring of the residues is representative of their hydrophobicity
(Larkin et al. 2007), ranging from high hydrophilicity (blue) to high
hydrophobicity (red). The numbering of the residues of the peptides is
according to the numbering of the entire V-ATPase subunit a (Nishi
and Forgac 2002)
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desired concentration to achieve each of three diVerent
peptide-to-SDS molar ratios of 1:250, 1:100, and 1:70 (the
Wnal concentrations of SDS were 500, 200 and 140 mM,
respectively). The obtained Wnal solutions were clear. Deion-
ized water was added to yield a ratio of 16:1 (vwater/vSDS).
The samples were mixed for 15 min and rapidly frozen
followed by drying under vacuum at ¡70°C. The dry samples
were rehydrated with deionized water (pH 6.0) resulting in
clear solutions. Samples of peptide sMTM7 in TFE were
prepared by dissolving the peptide in pure TFE. The Wnal
peptide concentration was 0.19 mM for all samples. In all
prepared SDS samples the concentration of SDS was well
above the cmc, which is 8 mM.
CD measurements
For the CD measurements, the sample preparation of pep-
tide sMTM7 in SDS micelles was performed as described
above. For each peptide-to-SDS ratio a freshly prepared
sample was used. The Wnal concentration of peptide
sMTM7 was determined spectrophotometrically by mea-
suring the UV absorbance at 280 nm, using an extinction
coeYcient of 7,210 l mol¡1 cm¡1 (Gill and von Hippel
1989). For all the experiments, the optical density at
280 nm was below 0.5.
All CD experiments were performed on a Jasco Spec-
tropolarimeter J-715 (Jasco, Tokyo, Japan), equipped with
a Peltier thermal-controlled cuvette holder. The spectra
were recorded using a 0.1-cm path length cuvette from 260
to 200 nm with a 1.0-nm step resolution and a response
time of 0.25 s. The spectra were collected and averaged
over 25 scans. To analyze the thermal stability of peptide
sMTM7 dissolved in the diVerent peptide-to-SDS ratios,
CD spectra were collected at 20, 30, 40 and 50°C. After
reaching the desired temperature the sample was allowed to
stabilize for 10 min after which the spectrum was mea-
sured. After the measurement at 50°C, the temperature was
lowered to 20°C and a spectrum was acquired to check for
reversibility of the conformation. CD spectra of TFE and
SDS solutions without the peptide with a SDS concentra-
tion equivalent to each peptide-to-SDS ratio were measured
as background and subtracted for each spectrum.
The secondary structure content of peptide sMTM7 was
calculated using the CD spectrum deconvolution software
CDNN (Bohm et al. 1992). This software calculates the
secondary structure of the peptide by comparison with a
CD database of known protein structures.
Fluorescence spectroscopy
For the Xuorescence measurements, the sample preparation
of peptide sMTM7 in TFE and SDS micelles was
performed as described above. Fluorescence spectra
were recorded on a Fluorolog 3.22 (Jobin Yvon-Spex,
Longjumeau, France) in quartz cuvettes with path lengths
of 10 and 4 mm in the excitation and emission direction,
respectively. Fluorescence spectra were recorded between
300 and 400 nm, using an excitation wavelength of 280 nm
and using excitation and emission slits giving a 2-nm band-
pass. Background Xuorescence from a sample without
peptide was subtracted from each spectrum.
Results
CD spectroscopy
Figure 2 shows the CD spectrum of peptide sMTM7 dis-
solved in TFE. The CD spectrum exhibits two negative
bands located at 208 and 222 nm combined with a positive
band near 200 nm, suggesting the presence of an -helical
conformation. This is conWrmed by secondary structure
analysis using CDNN (Table 1) that suggests that 50% of
the peptide populates an -helical conformation, whereas
the remaining peptide remains unstructured in TFE.
The CD spectra of peptide sMTM7 solubilized in the
diVerent SDS micellar solutions are presented in Fig. 3.
From the line shapes one can observe that the peptide
Fig. 2 Far-UV CD spectrum of peptide sMTM7 in TFE. The Wnal
peptide concentration was 0.19 mM. The temperature was 20°C
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Table 1 Secondary structure content of peptide sMTM7 in TFE and
SDS micelles at 20°C determined by the CDNN software (Bohm et al.
1992)
The standard error in the percentage is approximately §4%
Sample 
conditions
Secondary structure calculation (%)
-Helix -Sheet Unfolded
TFE 50 0 50
Peptide-to-SDS ratio
1:70 0 60 40
1:100 12 49 39
1:250 30 0 70642 Eur Biophys J (2010) 39:639–646
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adopts diVerent conformations for each of the three diVer-
ent peptide-to-SDS ratios used. When peptide sMTM7 is
dissolved in the highest concentration of SDS (47.5 mM of
SDS corresponding to the 1:250 ratio), the CD spectrum
shows two minima at 208 and 226 nm, suggesting that
peptide sMTM7 adopts an -helix conformation. Indeed,
spectral analysis obtained from CDNN (Table 1) indicates
that 30% of the peptide populates the -helix conformation
and the remaining 70% is unstructured.
By decreasing the amount of SDS molecules available to
solvate the peptide to an SDS concentration of 19 mM (i.e.,
a peptide-to-SDS ratio of 1:100), the CD spectrum of pep-
tide sMTM7 exhibits one strong minima at 222 nm and a
less pronounced minima at 210 nm. CDNN analysis of this
spectrum indicates that it arises from a linear combination
of CD signals originating from both -helix and -sheet
conformations (Table 1). In the SDS solution where the
concentration of detergent is further lowered to 13.3 mM of
SDS (corresponding to the 1:70 ratio), the CD spectrum of
peptide sMTM7 shows one minimum at 222 nm similar to
the one identiWed for the 1:100 ratio, however, with a lower
intensity. CDNN analysis (Table 1) indicates that 60% of
peptide sMTM7 populates the -sheet conformation and
the remaining 40% remains unstructured.
To analyze the thermal stability of the peptide at diVer-
ent peptide-to-SDS ratios, the CD spectra were recorded at
various temperatures. At the peptide-to-SDS ratios used,
the ellipticity changes with temperature in a linear way, but
no deWned unfolding transition is observed in the tempera-
ture range studied (spectra not shown). Upon cooling of
peptide sMTM7 back to 20°C, the ellipticity returns to its
original value for all the three peptide-to-SDS ratios stud-
ied. Thus, the conformational exchange between the -heli-
cal or -sheet and unfolded conformations of peptide
sMTM7 is fully reversible. The plot in Fig. 4 shows that
increasing the temperature leads to a more pronounced
decrease in the CD signal of the samples in which an -
helix conformation was found (i.e., peptide-to-SDS ratio
1:100 and 1:250). However, for the sample in which only
-sheet conformation was found (i.e., peptide-to-SDS ratio
1:70), the eVect of temperature is reduced.
Fluorescence experiments
Peptide sMTM7 contains a single tryptophan residue at
position 737 (W737). This opens the possibility to record
the Xuorescence spectra to provide information about the
polarity of the tryptophan environment (Lakowicz 2006).
The Xuorescence spectrum of peptide sMTM7 dissolved at
three peptide-to-SDS ratios using an excitation wavelength
of 280 nm exhibits a Xuorescence maximum for W737 at
330 nm (Fig. 5). By comparing the Xuorescence spectra
with diVerent excitation wavelengths, the sharp peak at
311 nm can be assigned to a Raman scattering peak. The
maximum of Xuorescence of peptide sMTM7 dissolved in
TFE is red-shifted to 340 nm. This suggests that when pep-
tide sMTM7 is solubilized in SDS micelles, W737 is located
in a more hydrophobic environment (Lakowicz 2006).
The intensities of the Xuorescence maximum of the spec-
tra in Fig. 5 show that an increase in the number of SDS mol-
ecules available to the peptide (from 1:70 to 1:250 ratios)
leads to an increase in Xuorescence intensity. This increase in
the signal intensity and the fact that the maximum is located
at the same wavelength lead to the conclusion that the pep-
tide is subject to self-quenching. This eVect could be due to
the formation of aggregated peptide sMTM7.
Discussion
Recently, several papers have been published about the
intrinsic conformational properties of a transmembrane
Fig. 3 Far-UV CD spectra of peptide sMTM7 solubilized at peptide-
to-SDS ratios of 1:250, 1:100, and 1:70. The Wnal peptide concentration
for all samples was 0.19 mM. The temperature was 20°C
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Fig. 4 Thermal stability experiments of peptide sMTM7 solubilized
at peptide-to-SDS ratios of 1:250, 1:100, and 1:70. The eVect of tem-
perature was monitored by measuring the ellipticity at 222 nm
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segment (TM7) located in the cytoplasmic hemi-channel
region of V-ATPase subunit a (Duarte et al. 2007a,  b;
Hesselink et al. 2005; Vos et al. 2006, 2007). These papers
provided detailed information about the low- and high-
resolution structure of this domain of V-ATPase that is
essential for proton translocation. A large part of the data
was obtained for peptides MTM7 and sMTM7 (Fig. 1) rep-
resenting the transmembrane region of TM7 dissolved in
DMSO as a membrane-mimicking organic solvent (Duarte
et al. 2007a, b).
In spite of the high-quality structural data obtained in
DMSO by 2D-NMR spectroscopy, it is still challenging to
understand the structural behavior of peptides MTM7 and
sMTM7 in detergent micelles. When dissolved at peptide-
to-SDS ratios of 1:100 and 1:250, peptide MTM7 adopts a
helical conformation (Duarte et al. 2007b). Meanwhile,
peptide sMTM7 is also known to adopt a helical conforma-
tion in SDS micelles (Vos et al. 2007). However, for the
last, only the peptide-to-SDS ratio of 1:1,600 was used and
no further information about the physicochemical behavior
of the peptide in the micelles was obtained. The present
paper focuses on a combined CD and Xuorescence study to
describe the solubilization and secondary structure charac-
terization of peptides MTM7 and sMTM7 in SDS micelles.
For peptide MTM7, we will rely on data from previously
published work, whereas here we will present new experi-
mental results for peptide sMTM7.
The CD data of peptide sMTM7 dissolved at three
peptide-to-SDS ratios (Table 1) indicate that the overall
conformation of the peptide is strongly inXuenced by the
detergent concentration, even above the detergent cmc.
Indeed, a decrease in the number of SDS molecules (from
1:250 to 1:100 to 1:70) available to solubilize peptide
sMTM7 leads to a conformational change -helix !
-sheet (Fig. 6). However, when the peptide is solubilized at
a peptide-to-SDS ratio of 1:250, the percentage of -helical
conformation is similar to the one detected previously for a
peptide-to-SDS ratio of 1:1,600 (Vos et al. 2007). The anal-
ysis of the CD spectra at a peptide-to-SDS ratio of 1:100
shows a mixture of -helix and -sheet conformations
(Table 1; Fig. 6). It is not evident from the CD results
whether diVerent peptides exhibiting -helix or -sheet
conformations at this ratio are located in diVerent micelles
(center illustration of Fig. 7), or whether they can exchange
conformations.
The temperature scans of the samples in which an
-helix conformation is present (1:100, 1:250) show a revers-
ible change in CD intensity, suggesting a conformational
exchange between -helix and unfolded conformations
(Fig. 4). Alternatively, the sample in which a -sheet
conformation is detected (1:70) is shown to be quite stable
as a function of temperature (Fig. 4), indicating that it is
not involved in an exchange with -helical or unfolded
Fig. 5 Fluorescence spectra of peptide sMTM7 dissolved at peptide-
to-SDS ratios of 1:250, 1:100, and 1:70 at an excitation wavelength of
280 nm. The emission peak at 311 nm is due to Raman scattering. The
Wnal peptide concentration for all samples was 0.19 mM. The temper-
ature was 20°C
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conformations. From these results, we might conclude that
at a peptide-to-SDS ratio of 1:100, 12% of peptide sMTM7
populating an -helix conformation can exchange with
unstructured peptide, while 49% of peptide populating the
-sheet is not involved with conformational exchange.
The position of the Xuorescence maximum of tryptophan
residue W737 of peptide sMTM7 remains the same at the
three peptide-to-SDS ratios studied (Fig. 5). This indicates
that this residue stays located in a region with the same
polarity. The change in Xuorescence intensity in Fig. 5 indi-
cates that at increasing peptide-to-SDS ratios, the peptide
tends to aggregate. This is concomitant with a -sheet for-
mation (Table 1), suggesting that the peptide forms -sheet
aggregates.
The relevant conformational data for peptides MTM7
and sMTM7 are summarized in Fig. 6. In this Wgure, the
number of micelles per peptide represents the theoretical
number of SDS micelles per peptide assuming that an SDS
micelle is composed of 60 SDS molecules. At peptide-to-
SDS ratios of 1:70 and 1:100, the number of available SDS
micelles (1 or about 2, respectively) for both peptides is
suYcient to stabilize the peptides in solution, however, the
number of micelles is not high enough to prevent aggrega-
tion and -sheet formation as is observed for peptide
sMTM7. In the case of a peptide-to-SDS ratio of 1:250, the
number of micelles becomes high enough (t4) to allow
both peptides to adopt an -helical conformation. Upon
increasing the SDS concentration to allow a peptide-to-
SDS ratio of 1:1,600, the -helical content does not
increase, whereas the number of micelles per peptide is
increased Wvefold.
From this analysis it is reasonable to assume that for
peptide-to-SDS ratios below 1:250, the peptide is in a
monomeric state with a stable -helical conformation sur-
rounded by SDS molecules forming a micellar-like struc-
ture. A schematic illustration of such a peptide-SDS
complex is shown in Fig. 7. Considering that tryptophan
W737 is in an SDS environment when it adopts an -helical
conformation, its polarity independence (Fig. 5) indicates a
similar environment when it aggregates adopting a -sheet
conformation. In this view we propose that monolayers of
-sheet aggregates are surrounded by SDS micelles in such
a way that W737 is always in contact with the SDS acyl
chains (Fig. 7).
A possible explanation for the SDS-dependent aggrega-
tional and conformational change of peptide sMTM7 could
be due to the limited way SDS molecules can stabilize the
-helix conformation. The primary sequence of peptide
sMTM7 contains several hydrophobic residues (Duarte
et al. 2007a), which could lead to strong hydrophobic inter-
actions with the SDS acyl chains. However, the peptide
contains a positively charged bulky arginine residue at
position 735 (R735) and a fraying C-terminal domain with
an unfolded conformation (Duarte et al. 2007a) that could
reduce the interaction with SDS molecules. Only with a
suYciently high number of SDS molecules, well above the
cmc will an energetically stable peptide-SDS complex be
formed with the peptide in a monomeric -helical confor-
mation. This conformation can be assumed to be the native
conformation of peptide sMTM7 (Duarte et al. 2007a; Vos
et al. 2007). If these conditions are not fulWlled already at
the sample preparation stage, the peptide will aggregate, the
-sheet being then the favorable conformation, i.e., similar
to that found for M13 coat protein (Spruijt and Hemminga
1991) and amyloid peptides (Bisaglia et al. 2006).
Based on the present information and published data
(Duarte et al. 2007b), it is interesting to carry out a compar-
ative study between peptides sMTM7 and MTM7 (Fig. 1)
dissolved and solubilized under diVerent conditions
(Fig. 6). Peptide MTM7 is a 37-residue peptide that con-
tains 35% of hydrophobic residues compared to the 28% of
peptide sMTM7. The conformational data of peptide
MTM7 in SDS micelles and DMSO indicate that this pep-
tide has a tendency to adopt an -helical conformation in
membrane-mimicking environments. The relatively low
percentage of helical content was explained previously
(Duarte et al. 2007b) to be due to (1) the presence of R735
in the center of the peptide sequence, which might interfere
Fig. 7 Schematic illustration of 
possible structures of peptide 
sMTM7 dissolved at diVerent 
peptide-to-SDS ratios. The or-
ange cylinders represent peptide 
sMTM7 in an -helical confor-
mation, the size of the cylinder is 
relative to the amount of detect-
ed -helix. The blue arrows 
represent peptide sMTM7 in a 
-sheet conformation. The red 
triangles represent arginine 
residue R735
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with the peptide solubilization in the micelles, and (2) the
fact that CD spectroscopy detected a low ellipticity due to
possible breaks in the helical segments, inducing a calcula-
tion of lower helical content.
In comparing the conformational results of peptide
MTM7 with those of peptide sMTM7, it is interesting to
note that, at an intermediate peptide-to-SDS ratio of 1:100,
peptide MTM7 exhibits an -helical conformation, while
peptide sMTM7 shows the presence of -helical and -sheet
conformations. This diVerence should primarily be due to
the removal of residues from the termini of peptide MTM7.
However, the decrease in length of the polypeptide chain
does not justify per se these conformational changes. One
eVect that might play a role is the presence of R735 in the
middle of both peptides, which can prevent the formation of
a well-Wtting SDS coat, hampering a correct solubilization of
the peptide. This eVect would also explain the more pro-
nounced instability of the short sMTM7 peptide as compared
to the longer MTM7 peptide. The higher stabilization of the
latter might be due to the higher number of amino acid resi-
dues that permit the formation of an -helical conformation.
In conclusion, both peptides MTM7 and sMTM7 are
highly hydrophobic, thus a high number of SDS molecules
is required to solubilize them in aqueous solution. The pres-
ence of arginine residue R735 in the center of the peptides,
due to its positively charged long side chain, imposes an
extra condition on the binding of SDS molecules. When the
available number of SDS molecules decreases, the bulky
positively charged arginine residue will tend to be solubi-
lized in the aqueous environment, while the SDS molecules
will cover the remaining peptide domains. This eVect is
more prominent in the shorter sMTM7 peptide due to the
lower number of residues that would permit the formation of
two -helices (before and after residue R735). We hypothe-
size that this decrease in the number of SDS molecules will
destabilize the helical conformation of the peptides and lead
to -sheet formation and subsequent aggregation.
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